Harrison.ai raised $92.3 million USD, Droplette secured $15.4M,Read more...
Canvs secured $5.6M; KTB Network led $4.5M funding for Qeexo; Arrayent landed additional $4M funding
- Arrayent announced that it has raised an additional $4 million in Series C funding from ORIX Ventures, adding to the initial $11 million it raised in September from DCM Ventures, Intel Capital, Opus Capital, Comerica Bank, and several angel investors. With this $15 million round, Arrayent has now raised $28 million in venture funding. The Redwood City, California-based Arrayent offers a platform that includes an operating system Connect Cloud, which hosts virtualized devices, the digital copy of the physical device to which the mobile apps connect.
- Qeexo, a company providing novel interaction experiences for mobile and other touch devices, today announced that it has raised $4.5 million in Series B funding led by KTB Network with participation from Inventec, Sierra Ventures, and Danhua Capital. Two years ago, the company raised $2.9 million in Series A funding from Sierra Ventures and Danhua Capital. Qeexo will use its new funding to expand its hiring initiatives (particularly in engineering, product management), operations, and R&D.
- Canvs, a technology platform created to measure and interpret emotions. On Thursday it announced that it raised a $5.6 million series A financing round led by KEC Ventures. Rubicon Ventures, Gary Vaynerchuck and BraVe Ventures, Social Starts, and Milestone Partners also participated. The company had previously raised a $1.5 million round in May of 2014, when it was known as Mashwork.
- Scale Venture Partners (ScaleVP) today announced that it has closed $335 million for its Scale Venture Partners V, L.P. from existing investors and several new partners. The Foster City-based firm previously raised $300 million for its Scale Venture Partners IV fund in May 2013. With the new fund, ScaleVP will stick to its primary focus area of enterprise software, especially those companies already seeing early traction with customers. Specifically, the firm says it will make investments of $5-25 million with its new fund, suggesting that it will focus on leading early-stage deals while also participating in later stage ones.
- TravelersBox, provider of airport kiosks for saving leftover foreign currency, today announced that it has secured a $10 million Series A round led by Arbor Ventures along with participation from existing investors. As part of the new round, Melissa Guzy of Arbor Ventures will join TravelersBox’s board of directors. To date, the company has raised $15.5 million in funding from Pitango Venture Capital, IPE Ventures, Pereg Ventures, iAngels, Global Blue, and angel investors Yuval Tal (founder and president of Payoneer), Zohar Gilon (managing partner at Tamar Ventures), Yanai Oron (general partner at Vertex Ventures Israel), Roy Gabriel, Moti Rivlin (CEO of Dragon Options), and Harel Kodesh (CTO of GE Software).
- Thrive Feeding today announced it has closed its seed funding round, raising $500,000 from private investors. The funding will be used to help bring the first real-time performance monitoring devices for baby feeding to market. Thrive Feeding has developed a patent pending technology that consists of a feeding bottle augmented by an electronics sensor module which captures and transmits detailed, real-time milk consumption data to a supporting mobile app in similar fashion to the way a fitness bracelet transmits steps or calories.
- Sentenai, a Boston, MA-based developer of cloud infrastructure that applies machine learning techniques to automate data engineering, closed a $1.8 million seed funding. Backers included Flybridge Capital Partners, Founder Collective, Project 11 Ventures, and Hyperplane Venture Capital. As part of the funding, Project 11 Ventures’ Reed Sturtevant will join the company’s Board of Directors, and Jeff Bussgang of Flybridge Capital and David Frankel of Founder Collective will serve as Board Observers. The company will use the funding to build out its engineering team and continue the development of its data delivery network.
- Nubo Software, a provider of Virtual Mobile Infrastructure (VMI) solutions, announced today it has completed a $7 million Series A financing round led by Magma Venture Partners along with Motorola Solutions Venture Capital. With this financing, Nubo plans to expand its marketing, sales and support services for its remote enterprise workspace solution.
- Vasopharm, a biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, today announced it has successfully raised €20 million (approximately $21.77 million) of new capital. The financing was co-led by existing investors Entrepreneurs Fund, Heidelberg Capital Private Equity and new investor, UK based Fort Rock Capital. Existing investors Bayern Kapital and funds advised by Hanseatic Asset Management LBG also participated in the round. Dr Mario Alberto Accardi, Venture Partner at Fort Rock Capital will be joining the Board of the company as a Non-Executive Director.
- Startups from Seattle and London are merging to form a new IT services company called Sendachi that today announced a $30 million investment from Columbia Capital. Seattle-based Clutch and London-based Contino have come together and now operate as Sendachi, which is headquartered in Seattle and will also utilize a U.K. office.
- Blend, a Silicon Valley technology company transforming the mortgage industry, today announces it raised $40 million in Series C funding led by Founders Fund. Lightspeed and Formation 8 are existing investors participating in the round. Blend will use these funds to continue to recruit top engineering talent and bring its platform to more lenders to originate efficient, data-driven mortgages.
- Olo, a digital ordering and delivery solutions for multi-location restaurants, today announced a $40 million minority investment from The Raine Group, a global merchant bank focused exclusively on technology, media, and telecommunications. The funds will be used to continue Olo’s rapid growth and to further enhance and develop its offerings.
- Malwarebytes, a security company that started when its cofounder was still a teenager fixing his parents’ infected computer, has come a long way from its bootstrapped roots. Today the startup’s software is used by millions of consumers and some 70,000 businesses to protect from and clean up computer viruses, worms, trojan horses and more. And now, to grow further, it is announcing that it has raised $50 million from Fidelity Management and Research Company.
- ForeScout Technologies Inc., a Campbell, CA-based provider of an agentless cybersecurity platform, secured $76 million in financing. The round, which valued ForeScout at $1 billion, was led by Wellington Management Company LLP. The company intends to use the funds to expand global field operations, build a support organization and increase R&D efforts to accelerate growth in the Internet of Things (IoT) security space.
If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to email@example.com.
Image source: imperial-consultants.co.uk
Support VatorNews by Donating
Read more from our "Daily Funding Roundup" series
Amazon Health sells healthcare services to Hilton; Athenahealth acquired for $17 BillionRead more...
How Microsoft can transform healthcare delivery; Trusted has raised $94M; Aptihealth landed $50Read more...
Related Companies, Investors, and Entrepreneurs
Joined Vator on
Scale Venture Partners chooses markets for investment based on our insights into trends drawn from primary research with incumbents, customers, competitors and our network of experts. We select companies we think are going after something great.
Our investment strategy makes "scale" relevant to you for two reasons. We operate in markets where you can create large scale success. We work side by side with you to help scale your business to reach its market potential.
Most of our investments are mid to late stage, when the software is being used, the chip is in the fab, and the therapy is being tested on humans. It may still feel early to you. You may be just starting to build out your go-to-market team. It's at this stage that our own practical operating experience drives the best rewards.